Nurix Therapeutics Overview

Nurix Therapeutics Research & Development

Research & Development expenses for NRIX.

Quarterly R&D Expenses

N/A

As of Feb 28, 2026

Annual R&D Expenses (TTM)

$245.12M

↑ 2.58% YoY

Trailing 12 months ending Feb 28, 2026

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin